Cargando…

TMIGD2 as a potential therapeutic target in glioma patients

INTRODUCTION: Among all types of central nervous system cancers, glioma remains the most frequent primary brain tumor in adults. Despite significant advances in immunomodulatory therapies, notably immune checkpoint inhibitors, their effectiveness remains constrained due to glioma resistance. The dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boulhen, Chaimae, AIT SSI, Saadia, Benthami, Hamza, Razzouki, Ibtissam, Lakhdar, Abdelhakim, Karkouri, Mehdi, Badou, Abdallah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227580/ https://www.ncbi.nlm.nih.gov/pubmed/37261362 http://dx.doi.org/10.3389/fimmu.2023.1173518

Ejemplares similares

High VISTA expression is linked to a potent epithelial-mesenchymal transition and is positively correlated with PD1 in breast cancer
por: Rezouki, Ibtissam, et al.
Publicado: (2023)

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer
por: Zohair, Basma, et al.
Publicado: (2023)

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
por: Miftah, Hayat, et al.
Publicado: (2023)

A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
por: Rafii, Soumaya, et al.
Publicado: (2023)

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
por: Ait Ssi, Saadia, et al.
Publicado: (2021)

The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
por: Kone, Abdou-samad, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

TMIGD1: Emerging functions of a tumor supressor and adhesion receptor
por: Thüring, Eva-Maria, et al.
Publicado: (2023)

Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1
por: Thüring, Eva-Maria, et al.
Publicado: (2023)

Glioblastoma Following Treated Medulloblastoma After 29 Years in the Posterior Fossa: Case Report and Review of Literature
por: Mesbahi, Tarek, et al.
Publicado: (2022)

The cell adhesion molecule TMIGD1 binds to moesin and regulates tubulin acetylation and cell migration
por: Rahimi, Nader, et al.
Publicado: (2021)

Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging
por: Li, Deling, et al.
Publicado: (2020)

TMIGD1 Inhibited Abdominal Adhesion Formation by Alleviating Oxidative Stress in the Mitochondria of Peritoneal Mesothelial Cells
por: Wu, Yunhua, et al.
Publicado: (2021)

Emerging Roles of L-Type Voltage-Gated and Other Calcium Channels in T Lymphocytes
por: Badou, Abdallah, et al.
Publicado: (2013)

Pediatric CHANCE fracture treated by lumbar lacing technique: a case report
por: Haouas, Mohammed Yassine, et al.
Publicado: (2023)

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
por: Yu, Kai, et al.
Publicado: (2022)

CAR T-cells for colorectal cancer immunotherapy: Ready to go?
por: Ghazi, Bouchra, et al.
Publicado: (2022)

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022)

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression
por: Iyer, Swathi V., et al.
Publicado: (2016)

A new DNA marker of the TMIGD1 gene used to identify high fertilization rates in Tsaiya ducks (Anas platyrhynchos)
por: HUANG, Hsiu-Lin, et al.
Publicado: (2018)

The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion molecule TMIGD1 and can recruit it to mitochondria
por: Hartmann, Christian, et al.
Publicado: (2020)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
por: Tezcan, Gulcin, et al.
Publicado: (2021)

Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease
por: Zhou, Longyuan, et al.
Publicado: (2023)

From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma
por: Smith, Gregory T., et al.
Publicado: (2022)

Primary dural lymphoma: Case report
por: Saidy, Jihane, et al.
Publicado: (2022)

TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer
por: Meyer, Rosana D., et al.
Publicado: (2017)

Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment
por: Zhou, Xianzhe, et al.
Publicado: (2023)

TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
por: Li, Shasha, et al.
Publicado: (2023)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

Origin, activation, and targeted therapy of glioma-associated macrophages
por: Xu, Can, et al.
Publicado: (2022)

Pre-clinical models for evaluating glioma targeted immunotherapies
por: Frederico, Stephen C., et al.
Publicado: (2023)

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
por: Rafii, Soumaya, et al.
Publicado: (2023)

Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses
por: Peng, Jinwu, et al.
Publicado: (2022)

The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies
por: Liu, Hao, et al.
Publicado: (2023)

Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
por: Asija, Sweety, et al.
Publicado: (2023)

Tetraspanins as Potential Therapeutic Candidates for Targeting Flaviviruses
por: Ahmed, Waqas, et al.
Publicado: (2021)

Novel potential therapeutic targets of alopecia areata
por: Xu, Wen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qgc4tkqqp4hu54nl3anb2b6gud